Chemical Compound

Di-Norbudesonide

CAS Registry Number 1040085-98-0
Di-Norbudesonide chemical structure
Primary Record

Di-Norbudesonide

In stock
3,575 g
Purity
99.1 %
CAS
1040085-98-0

Compound Identifiers & Properties

CAS
1040085-98-0
PubChem CID
13298167
SMILES
CC1O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@@]5([C@H]4[C@H](C[C@@]3([C@@]2(O1)C(=O)CO)C)O)C
Canonical SMILES
CC1O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@]2(C(=O)CO)O1

Names & Synonyms

  • Di-Norbudesonide
  • NI0AGY81EG
  • Budesonide Impurity B
  • Budesonide EP Impurity B
  • UNII-NI0AGY81EG
  • (Mixture of Diastereomers)
  • 1040085-98-0
  • SCHEMBL13524231
  • FE146156
  • Budesonide acetaldehyde acetal (epimers) [USP]
  • Di-Norbudesonide(Mixture of Diastereomers)
  • BUDESONIDE IMPURITY B [EP IMPURITY]
  • CS-0166430
  • BUDESONIDE ACETALDEHYDE ACETAL (EPIMERS)
  • Budesonide EP Impurity BMixture of diastereomers
  • 16alpha,17-(Ethylidenebis(oxy))-11beta,21-dihydroxypregna-1,4-diene-3,20-dione
  • (1S,2S,4R,8S,9S,11S,12S,13R)-11-Hydroxy-8-(2-hydroxyacetyl)-6,9,13-trimethyl-5,7-dioxapentacyclo[10.8.0.02,9.04,8.013,18]icosa-14,17-dien-16-one
  • 16alpha,17-[(1RS)-Ethylidenebis(oxy)]-11beta,21-dihydroxypregna-1,4-diene-3,20-dione
  • (6aR,6bS,7S,8aS,8bS,11aR,12aS,12bS)-7-hydroxy-8b-(2-hydroxyacetyl)-6a,8a,10-trimethyl-1,2,6a,6b,7,8,8a,8b,11a,12,12a,12b-dodecahydro-4H-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-4-one
  • Budesonide EP Impurity B (D-Homo Budesonide (Mixture of Diastereomers))
  • Pregna-1,4-diene-3,20-dione, 16,17-(ethylidenebis(oxy))-11,21-dihydroxy-, (11beta,16alpha)-
  • Pregna-1,4-diene-3,20-dione, 16,17-[ethylidenebis(oxy)]-11,21-dihydroxy-, (11beta,16alpha)-
  • (11beta,16alpha)-16,17-[Ethylidenebis(oxy)]-11,21-dihydroxypregna-1,4-diene-3,20-dione
  • 16,17-[(1RS)-ethylidenebis(oxy)]-11,21-dihydroxypregna-1,4-diene-3,20-dione
  • (11?,16?)-16,17-[(1RS)-Ethylidenebis(oxo)]-11,21-dihydroxypregna-1,4-diene-3,20-dione
  • (11beta,16alpha)-16,17-[(1RS)-Ethylidenebis(oxo)]-11,21-dihydroxypregna-1,4-diene-3,20-dione
  • (1S,2S,4R,8S,9S,11S,12S,13R)-11-hydroxy-8-(2-hydroxyacetyl)-6,9,13-trimethyl-5,7-dioxapentacyclo[10.8.0.0.0.0]icosa-14,17-dien-16-one
  • (1S,2S,4R,8S,9S,11S,12S,13R)-11-hydroxy-8-(2-hydroxyacetyl)-6,9,13-trimethyl-5,7-dioxapentacyclo[10.8.0.02?.0??.0131?]icosa-14,17-dien-16-one
  • (6aR,6bS,7S,8aS,8bS,11aR,12aS,12bS)-7-hydroxy-8b-(2-hydroxyacetyl)-6a,8a,10-trimethyl-6a,6b,7,8,8a,8b,11a,12,12a,12b-decahydro-1H-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-4(2H)-one (Budesonide Impurity
  • 16,17-[Ethylidenebis(oxy)]-11,21-dihydroxypregna-1,4-diene-3,20-dione, (11beta,16alpha)-
  • 16alpha,17-[(1RS)-Ethylidenebis(oxy)]-11beta,21-dihydroxypregna-1,4-diene-3,20-dione; Budesonide Imp. B (EP); Budesonide Impurity B